Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


Articles published in Scand J Rheumatol

Retrieve available abstracts of 90 articles:
HTML format



Single Articles


    July 2022
  1. KRIJBOLDER DI, Verstappen M, Wouters F, Lard LR, et al
    Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgia.
    Scand J Rheumatol. 2022;51:284-290.
    PubMed     Abstract available


    June 2022
  2. ZHANG K, Jia Y, Wang R, Guo D, et al
    Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study.
    Scand J Rheumatol. 2022 Jun 6:1-7. doi: 10.1080/03009742.2022.2070988.
    PubMed     Abstract available


    May 2022
  3. VENETSANOPOULOU AI, Alamanos Y, Skalkou A, Voulgari PV, et al
    The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre.
    Scand J Rheumatol. 2022 May 12:1-8. doi: 10.1080/03009742.2022.2058178.
    PubMed     Abstract available


  4. LEE NY, Kim NR, Kang JW, Kim G, et al
    Increased salivary syndecan-1 level is associated with salivary gland function and inflammation in patients with Sjogren's syndrome.
    Scand J Rheumatol. 2022;51:220-229.
    PubMed     Abstract available


  5. FOHSE FK, Rollefstad S, Ikdahl E, Wibetoe G, et al
    Degree of arterial stiffness is comparable across inflammatory joint disease entities.
    Scand J Rheumatol. 2022;51:186-195.
    PubMed     Abstract available


    April 2022
  6. DIEPERINK SS, Glintborg B, Oestergaard LB, Norgaard M, et al
    Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study.
    Scand J Rheumatol. 2022 Apr 20:1-9. doi: 10.1080/03009742.2022.2049057.
    PubMed     Abstract available


    March 2022
  7. HESLINGA M, Teunissen C, Agca R, van der Woude D, et al
    NT-proBNP and sRAGE levels in early rheumatoid arthritis.
    Scand J Rheumatol. 2022 Mar 11:1-7. doi: 10.1080/03009742.2022.2042975.
    PubMed     Abstract available


  8. ALSING CL, Nystad TW, Igland J, Gjesdal CG, et al
    Trends in the occurrence of ischaemic heart disease over time in rheumatoid arthritis: 1821 patients from 1972 to 2017.
    Scand J Rheumatol. 2022 Mar 11:1-10. doi: 10.1080/03009742.2022.2040116.
    PubMed     Abstract available


  9. RUWAARD J, L' Ami MJ, Kneepkens EL, Krieckaert C, et al
    Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial.
    Scand J Rheumatol. 2022 Mar 2:1-8. doi: 10.1080/03009742.2022.2028364.
    PubMed     Abstract available


  10. LIU Y, Wang Z, Ren L, Zeng Q, et al
    Sonographic findings of immunoglobulin G4-related sialadenitis and differences from Sjogren's syndrome.
    Scand J Rheumatol. 2022;51:128-134.
    PubMed     Abstract available


    January 2022
  11. SKOVSGAARD CV, Kruse M, Hjollund N, Maribo T, et al
    Cost-effectiveness of a telehealth intervention in rheumatoid arthritis: economic evaluation of the Telehealth in RA (TeRA) randomized controlled trial.
    Scand J Rheumatol. 2022 Jan 20:1-11. doi: 10.1080/03009742.2021.2008604.
    PubMed     Abstract available


  12. NIELSEN MA, Koster D, Greisen S, Troldborg A, et al
    Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-9. doi: 10.1080/03009742.2021.1992860.
    PubMed     Abstract available


  13. MOLANDER V, Bower H, Askling J
    Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-7. doi: 10.1080/03009742.2021.2001907.
    PubMed     Abstract available


  14. GLOYER L, Golumba-Nagy V, Meyer A, Yan S, et al
    Adenosine receptor A2a blockade by caffeine increases IFN-gamma production in Th1 cells from patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-5. doi: 10.1080/03009742.2021.1995956.
    PubMed     Abstract available


  15. CARRARA G, Argnani L, Zanetti A, Zabotti A, et al
    Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology.
    Scand J Rheumatol. 2022 Jan 13:1-5. doi: 10.1080/03009742.2021.2003033.
    PubMed     Abstract available


  16. KEROLA AM, Rollefstad S, Kazemi A, Wibetoe G, et al
    Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents.
    Scand J Rheumatol. 2022 Jan 11:1-9. doi: 10.1080/03009742.2021.1997436.
    PubMed     Abstract available


  17. UHRENHOLT L, Christensen R, Dreyer L, Schlemmer A, et al
    Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study.
    Scand J Rheumatol. 2022;51:25-33.
    PubMed     Abstract available


  18. OTTAVIANI S, Khaleche S, Borie R, Debray MP, et al
    Rheumatological evaluation of patients with interstitial lung disease.
    Scand J Rheumatol. 2022;51:34-41.
    PubMed     Abstract available


  19. KITADA T, Kadoba K, Watanabe R, Koyama T, et al
    Listeriosis presenting with fever, arthralgia, elevated liver enzymes, and hyperferritinaemia in pregnancy: a critical mimicker of adult-onset Still's disease.
    Scand J Rheumatol. 2022;51:78-80.
    PubMed    


    December 2021
  20. SOUSSI BG, Cordtz RL, Kristensen S, Bork CS, et al
    Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study.
    Scand J Rheumatol. 2021 Dec 16:1-9. doi: 10.1080/03009742.2021.1957557.
    PubMed     Abstract available


    November 2021
  21. THOMSEN T, Esbensen BA, Hetland ML, Aadahl M, et al
    Characteristics of participants and decliners from a randomized controlled trial on physical activity in patients with rheumatoid arthritis: a retrospective register-based cross-sectional study.
    Scand J Rheumatol. 2021 Nov 2:1-8. doi: 10.1080/03009742.2021.1975394.
    PubMed     Abstract available


  22. GEHIN JE, Warren DJ, Syversen SW, Lie E, et al
    Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study.
    Scand J Rheumatol. 2021;50:445-454.
    PubMed     Abstract available


    October 2021
  23. PALTTA J, Heikkila HK, Pirila L, Eklund KK, et al
    The validity of rheumatoid arthritis diagnoses in Finnish biobanks.
    Scand J Rheumatol. 2021 Oct 13:1-9. doi: 10.1080/03009742.2021.1967047.
    PubMed     Abstract available


  24. ANGSTROM L, Hornberg K, Sundstrom B, Sodergren A, et al
    Rheumatoid cachexia in early rheumatoid arthritis: prevalence and associated variables.
    Scand J Rheumatol. 2021 Oct 13:1-7. doi: 10.1080/03009742.2021.1973678.
    PubMed     Abstract available


  25. AMRIS K, Bandak E, Kristensen LE, Waehrens EE, et al
    Agreement between self-reported and observed functioning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia, and the influence of pain and fatigue: a cross-sectional study.
    Scand J Rheumatol. 2021 Oct 1:1-9. doi: 10.1080/03009742.2021.1952755.
    PubMed     Abstract available


    September 2021
  26. JENSEN R, Christensen AF, Hartlev LB, Thomsen JS, et al
    Calcified cartilage differs in patients with end-stage primary osteoarthritis and secondary osteoarthritis due to rheumatoid arthritis of the hip joint.
    Scand J Rheumatol. 2021 Sep 13:1-11. doi: 10.1080/03009742.2021.1952754.
    PubMed     Abstract available


  27. THOMAS PE, Aarestrup J, Jacobsen S, Jensen BW, et al
    Birthweight, body size, and growth during childhood and risks of rheumatoid arthritis: a large Danish cohort study.
    Scand J Rheumatol. 2021 Sep 13:1-9. doi: 10.1080/03009742.2021.1954772.
    PubMed     Abstract available


  28. BERTRAND D, Stouten V, De Cock D, Pazmino S, et al
    Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial.
    Scand J Rheumatol. 2021 Sep 13:1-11. doi: 10.1080/03009742.2021.1955467.
    PubMed     Abstract available


  29. MARS N, Kerola AM, Kauppi MJ, Pirinen M, et al
    Cluster analysis identifies unmet healthcare needs among patients with rheumatoid arthritis.
    Scand J Rheumatol. 2021 Sep 13:1-8. doi: 10.1080/03009742.2021.1944306.
    PubMed     Abstract available


  30. NAKAYAMA Y, Hashimoto M, Watanabe R, Murakami K, et al
    Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study.
    Scand J Rheumatol. 2021 Sep 13:1-10. doi: 10.1080/03009742.2021.1947005.
    PubMed     Abstract available


  31. MOLLER-BISGAARD S, Horslev-Petersen K, Ejbjerg B, Hetland ML, et al
    Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.
    Scand J Rheumatol. 2021 Sep 2:1-11. doi: 10.1080/03009742.2021.1935312.
    PubMed     Abstract available


  32. ENDO Y, Kawashiri SY, Nishino A, Michitsuji T, et al
    Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan.
    Scand J Rheumatol. 2021 Sep 2:1-9. doi: 10.1080/03009742.2021.1927389.
    PubMed     Abstract available


  33. ANDERSSON M, Svensson B, Bergman S
    Pain in rheumatoid arthritis: a seven-year follow-up study of pain distribution and factors associated with transition from and to chronic widespread pain.
    Scand J Rheumatol. 2021 Sep 1:1-10. doi: 10.1080/03009742.2021.1944304.
    PubMed     Abstract available


  34. CIAFFI J, Giuggioli D, Spinella A, Meliconi R, et al
    Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy.
    Scand J Rheumatol. 2021;50:411-412.
    PubMed    


    July 2021
  35. VUOLTEENAHO K, Tuure L, Nieminen R, Laasonen L, et al
    Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.
    Scand J Rheumatol. 2021 Jul 15:1-6. doi: 10.1080/03009742.2021.1929456.
    PubMed     Abstract available


  36. CAO C, Shao Q, Yang H
    Sjogren's syndrome concurrent with organizing pneumonia with secondary systemic capillary leak syndrome: a case report.
    Scand J Rheumatol. 2021;50:322-324.
    PubMed    


    June 2021
  37. PEDERSEN JK, Andersen K, Svendsen AJ, Horslev-Petersen K, et al
    No difference in antidepressant prescription in rheumatoid arthritis and controls. Results from a population-based, matched inception cohort.
    Scand J Rheumatol. 2021 Jun 29:1-7. doi: 10.1080/03009742.2021.1923148.
    PubMed     Abstract available


  38. MCCOY SS, Greenlee RT, VanWormer JJ, Schletzbaum M, et al
    Smoking associated with reduced odds of Sjogren's syndrome among rheumatoid arthritis patients.
    Scand J Rheumatol. 2021 Jun 25:1-5. doi: 10.1080/03009742.2021.1925584.
    PubMed     Abstract available


  39. VERSTEEG GA, Steunebrink L, Vonkeman HE, Ten Klooster PM, et al
    Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission.
    Scand J Rheumatol. 2021 Jun 21:1-10. doi: 10.1080/03009742.2021.1917161.
    PubMed     Abstract available


  40. TAN YK, Teo P, Saffari SE, Xin X, et al
    A musculoskeletal ultrasound program as an intervention to improve disease modifying anti-rheumatic drugs adherence in rheumatoid arthritis: a randomized controlled trial.
    Scand J Rheumatol. 2021 Jun 10:1-9. doi: 10.1080/03009742.2021.1901416.
    PubMed     Abstract available


    May 2021
  41. SCHAFER C
    Early description of polyarthritis possibly representing rheumatoid arthritis given by a patient, as recorded in a textbook on gout from 1788.
    Scand J Rheumatol. 2021 May 5:1-2. doi: 10.1080/03009742.2021.1894824.
    PubMed    


  42. ELOFF E, Martinsson K, Ziegelasch M, Cedergren J, et al
    Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.
    Scand J Rheumatol. 2021;50:189-197.
    PubMed     Abstract available


    April 2021
  43. GAO J, Xin L, Guo Q, Xu K, et al
    Twenty-year changes in mortality rates and underlying causes of death in patients with rheumatoid arthritis-associated interstitial lung disease.
    Scand J Rheumatol. 2021 Apr 14:1-5. doi: 10.1080/03009742.2021.1882557.
    PubMed     Abstract available


    March 2021
  44. BRUNET SC, Tse JJ, Kuczynski MT, Engelke K, et al
    Heterogenous bone response to biologic DMARD therapies in rheumatoid arthritis patients and their relationship to functional indices.
    Scand J Rheumatol. 2021 Mar 29:1-10. doi: 10.1080/03009742.2020.1869303.
    PubMed     Abstract available


  45. KNUDSEN SS, Thomsen A, Deleuran BW, Bech BH, et al
    Maternal rheumatoid arthritis during pregnancy and neurodevelopmental disorders in offspring: a systematic review.
    Scand J Rheumatol. 2021 Mar 23:1-9. doi: 10.1080/03009742.2021.1882559.
    PubMed     Abstract available


  46. AGCA R, Heslinga M, Raterman HG, Simsek S, et al
    Coexistent subclinical hypothyroidism is associated with an increased risk of new cardiovascular events in rheumatoid arthritis: an explorative study.
    Scand J Rheumatol. 2021 Mar 23:1-4. doi: 10.1080/03009742.2021.1891279.
    PubMed     Abstract available


  47. TER WEE MM, Raterman HG, van Schoor NM, Deeg D, et al
    Accuracy of an algorithm to identify rheumatoid arthritis in the Longitudinal Ageing Study Amsterdam population: a validation study.
    Scand J Rheumatol. 2021 Mar 15:1-5. doi: 10.1080/03009742.2020.1852442.
    PubMed     Abstract available


  48. ENDO Y, Kawashiri SY, Nishino A, Okamoto M, et al
    Discrepancy between clinical and ultrasound remissions in rheumatoid arthritis: a multicentre ultrasound cohort study in Japan.
    Scand J Rheumatol. 2021 Mar 15:1-6. doi: 10.1080/03009742.2021.1876914.
    PubMed     Abstract available


  49. BERGSTROM M, Dahlstrom O, Thyberg I, Bjork M, et al
    The role of support from significant others in the association between disease-related factors and sickness absence in early rheumatoid arthritis: a longitudinal study.
    Scand J Rheumatol. 2021 Mar 6:1-8. doi: 10.1080/03009742.2020.1870712.
    PubMed     Abstract available


  50. RAJAMOHAN A, Heit B, Cairns E, Barra L, et al
    Citrullinated and homocitrullinated low- density lipoprotein in rheumatoid arthritis.
    Scand J Rheumatol. 2021 Mar 6:1-8. doi: 10.1080/03009742.2020.1867237.
    PubMed     Abstract available


  51. D'AMICO ME, Silvagni E, Carrara G, Zanetti A, et al
    Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases.
    Scand J Rheumatol. 2021 Mar 4:1-10. doi: 10.1080/03009742.2020.1855365.
    PubMed     Abstract available


  52. SHAO Q, Wang S, Jiang H, Liu L, et al
    Efficacy and safety of iguratimod on patients with primary Sjogren's syndrome: a randomized, placebo-controlled clinical trial.
    Scand J Rheumatol. 2021;50:143-152.
    PubMed     Abstract available


  53. KONONOFF A, Horkko S, Pussinen P, Kautiainen H, et al
    Antibodies to malondialdehyde-acetaldehyde modified low-density lipoprotein in patients with newly diagnosed inflammatory joint disease.
    Scand J Rheumatol. 2021;50:113-117.
    PubMed     Abstract available


  54. LAVERE P, Sonkar J, Du X, Qian YW, et al
    Macrophage activation syndrome complicating adult onset Still's disease: a case report.
    Scand J Rheumatol. 2021;50:161-162.
    PubMed    


    February 2021
  55. SCHELIN M, Westerlind H, Lindqvist J, Englid E, et al
    Widespread non-joint pain in early rheumatoid arthritis.
    Scand J Rheumatol. 2021 Feb 25:1-9. doi: 10.1080/03009742.2020.1846778.
    PubMed     Abstract available


  56. PRIMDAHL J, Esbensen BA, Pedersen AK, Bech B, et al
    Validation of the Danish versions of the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaires (BRAFs).
    Scand J Rheumatol. 2021 Feb 19:1-9. doi: 10.1080/03009742.2020.1869301.
    PubMed     Abstract available


  57. ZIEGELASCH M, Forslind K
    Simplified Larsen erosion score (SLES) for estimating joint damage in early rheumatoid arthritis in clinical practice.
    Scand J Rheumatol. 2021 Feb 16:1-2. doi: 10.1080/03009742.2020.1846780.
    PubMed    


  58. MA JD, Chen CT, Lin JZ, Li QH, et al
    Muscle wasting, a neglected complication associated with physical dysfunction in elderly patients with rheumatoid arthritis: a cross-sectional observational study.
    Scand J Rheumatol. 2021 Feb 8:1-10. doi: 10.1080/03009742.2020.1842902.
    PubMed     Abstract available


    January 2021
  59. HAMMER HB, Hansen I, Jarvinen P, Leirisalo-Repo M, et al
    Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis.
    Scand J Rheumatol. 2021 Jan 19:1-9. doi: 10.1080/03009742.2020.1845394.
    PubMed     Abstract available


  60. HEDENSTIERNA L, Opava CH, Askling J, Jiang X, et al
    Social stressors and risk of rheumatoid arthritis and their relationship to known modifiable risk factors: results from the Swedish EIRA study.
    Scand J Rheumatol. 2021 Jan 12:1-5. doi: 10.1080/03009742.2020.1813325.
    PubMed     Abstract available


    December 2020
  61. JONSSON AB, Johansen CV, Rolving N, Pfeiffer-Jensen M, et al
    Feasibility and estimated efficacy of blood flow restricted training in female patients with rheumatoid arthritis: a randomized controlled pilot study.
    Scand J Rheumatol. 2020 Dec 10:1-9. doi: 10.1080/03009742.2020.1829701.
    PubMed     Abstract available


    November 2020
  62. XU X, Estekizadeh A, Davoudi B, Varani S, et al
    Detection of human cytomegalovirus in synovial neutrophils obtained from patients with rheumatoid arthritis.
    Scand J Rheumatol. 2020 Nov 27:1-6. doi: 10.1080/03009742.2020.1825798.
    PubMed     Abstract available


  63. KOIVUNIEMI R, Kuuliala A, Kivisto S, Holmstrom M, et al
    Induction of remission in female rheumatoid arthritis patients is associated with stabilization of myocardial abnormalities: a prospective cardiac magnetic resonance follow-up study.
    Scand J Rheumatol. 2020 Nov 27:1-9. doi: 10.1080/03009742.2020.1818819.
    PubMed     Abstract available


    October 2020
  64. KAWASHIRI SY, Nishino A, Shimizu T, Takatani A, et al
    Fluorescence optical imaging in patients with active rheumatoid arthritis: a comparison with ultrasound and an association with biomarkers.
    Scand J Rheumatol. 2020 Oct 21:1-9. doi: 10.1080/03009742.2020.1794028.
    PubMed     Abstract available


  65. DREWES AM, Brock C, Rasmussen SE, Moller HJ, et al
    Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study.
    Scand J Rheumatol. 2020 Oct 13:1-8. doi: 10.1080/03009742.2020.1764617.
    PubMed     Abstract available


  66. SIDIRAS P, Spruyt D, Gangji V, Imbault V, et al
    Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.
    Scand J Rheumatol. 2020 Oct 7:1-6. doi: 10.1080/03009742.2020.1798500.
    PubMed     Abstract available


    September 2020
  67. ITAMIYA T, Komai T, Tsuchida Y, Shoda H, et al
    Varicella zoster virus myelitis in a patient with rheumatoid arthritis treated by tofacitinib.
    Scand J Rheumatol. 2020 Sep 17:1-3. doi: 10.1080/03009742.2020.1800082.
    PubMed    


  68. ENDO Y, Koga T, Kawashiri SY, Morimoto S, et al
    Significance of anti-Ro/SSA antibodies in the response and retention of abatacept in patients with rheumatoid arthritis: a multicentre cohort study.
    Scand J Rheumatol. 2020 Sep 3:1-5. doi: 10.1080/03009742.2020.1772361.
    PubMed     Abstract available


  69. SHIMIZU H, Nishioka H
    Adult-onset Still's disease accompanied by erythema multiforme presenting as an atypical rash.
    Scand J Rheumatol. 2020;49:422-423.
    PubMed    


    August 2020
  70. ZIEGELASCH M, Boman A, Martinsson K, Thyberg I, et al
    Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006-2011.
    Scand J Rheumatol. 2020 Aug 28:1-9. doi: 10.1080/03009742.2020.1771761.
    PubMed     Abstract available


  71. LEU AGELII M, Andersson M, Jones BL, Sjowall C, et al
    Disease activity trajectories in rheumatoid arthritis: a tool for prediction of outcome.
    Scand J Rheumatol. 2020 Aug 28:1-10. doi: 10.1080/03009742.2020.1774646.
    PubMed     Abstract available


  72. DURYEA J, Gravallese EM, Wortman JR, Xu C, et al
    Healing of erosions in rheumatoid arthritis remains elusive: results with 24 months of the anabolic agent teriparatide.
    Scand J Rheumatol. 2020 Aug 6:1-4. doi: 10.1080/03009742.2020.1772362.
    PubMed     Abstract available


    July 2020
  73. BJORSENIUS I, Rantapaa-Dahlqvist S, Berglin E, Sodergren A, et al
    Extent of atherosclerosis after 11-year prospective follow-up in patients with early rheumatoid arthritis was affected by disease severity at diagnosis.
    Scand J Rheumatol. 2020 Jul 21:1-9. doi: 10.1080/03009742.2020.1767200.
    PubMed     Abstract available


  74. HUSBERG M, Bernfort L, Hallert E
    Presence of anti-citrullinated protein antibodies and costs and disease activity in early rheumatoid arthritis - a 3-year follow-up.
    Scand J Rheumatol. 2020 Jul 20:1-10. doi: 10.1080/03009742.2020.1750688.
    PubMed     Abstract available


  75. ZHANG Y, Peltonen M, Andersson-Assarsson JC, Svensson PA, et al
    Elevated adiponectin predicts the development of rheumatoid arthritis in subjects with obesity.
    Scand J Rheumatol. 2020 Jul 15:1-9. doi: 10.1080/03009742.2020.1753808.
    PubMed     Abstract available


  76. NYSTAD TW, Fenstad AM, Fevang BT
    Major differences in medical and surgical treatment of psoriatic arthritis and rheumatoid arthritis: a comparison of two historic cohorts.
    Scand J Rheumatol. 2020;49:267-270.
    PubMed     Abstract available


  77. HONDA M, Moriyama M, Kondo M, Kumakura S, et al
    Tofacitinib-induced remission in refractory adult-onset Still's disease complicated by macrophage activation syndrome.
    Scand J Rheumatol. 2020;49:336-338.
    PubMed    


    June 2020
  78. SVENSSON B, Forslind K, Andersson M
    Unacceptable pain in the BARFOT inception cohort of patients with rheumatoid arthritis: a long-term study.
    Scand J Rheumatol. 2020 Jun 4:1-8. doi: 10.1080/03009742.2020.1729404.
    PubMed     Abstract available


  79. WOUTERS F, Matthijssen X, Boeters DM, Ten Brinck RM, et al
    Do magnetic resonance imaging-detected erosions predict progression to rheumatoid arthritis in patients presenting with clinically suspect arthralgia? A longitudinal study.
    Scand J Rheumatol. 2020 Jun 2:1-7. doi: 10.1080/03009742.2020.1737221.
    PubMed     Abstract available


    May 2020
  80. EMERY P, Suh CH, Weinblatt ME, Smolen JS, et al
    Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis.
    Scand J Rheumatol. 2020 May 29:1-10. doi: 10.1080/03009742.2020.1732458.
    PubMed     Abstract available


  81. MATSUOKA H, Kabata D, Taura A, Matsui T, et al
    Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis.
    Scand J Rheumatol. 2020;49:253-255.
    PubMed    


  82. VASAITIS L, Nordmark G, Theander E, Backlin C, et al
    Population-based study of patients with primary Sjogren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences.
    Scand J Rheumatol. 2020;49:225-232.
    PubMed     Abstract available


  83. AYAR K, Tunc R, Pekel H, Esen HH, et al
    Prevalence of sicca symptoms and Sjogren's syndrome in coeliac patients and healthy controls.
    Scand J Rheumatol. 2020;49:233-238.
    PubMed     Abstract available


    April 2020
  84. RODRIGUEZ-MUGURUZA S, Combe B, Guillemin F, Fautrel B, et al
    Predictors of fatigue and persistent fatigue in early rheumatoid arthritis: a longitudinal observational study, data from the ESPOIR cohort.
    Scand J Rheumatol. 2020 Apr 30:1-8. doi: 10.1080/03009742.2020.1726449.
    PubMed     Abstract available


  85. VINCI C, Infantino M, Raturi S, Tindell A, et al
    Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritis.
    Scand J Rheumatol. 2020 Apr 21:1-11. doi: 10.1080/03009742.2020.1713395.
    PubMed     Abstract available


  86. BOZOVIC G, Larsson H, Wuttge DM, Hakansson M, et al
    Successful lung transplantation in a patient with rheumatoid arthritis suffering from obliterative bronchiolitis.
    Scand J Rheumatol. 2020 Apr 16:1-2. doi: 10.1080/03009742.2020.1727006.
    PubMed    


    March 2020
  87. DAVIES K, Collins A, Charlton FG, Ng WF, et al
    Nodular localized primary cutaneous amyloidosis and primary Sjogren's syndrome.
    Scand J Rheumatol. 2020;49:159-160.
    PubMed    


    January 2020
  88. HEUS A, Arends S, Van Nimwegen JF, Stel AJ, et al
    Pulmonary involvement in primary Sjogren's syndrome, as measured by the ESSDAI.
    Scand J Rheumatol. 2020;49:38-46.
    PubMed     Abstract available


  89. ORNBJERG LM, Christensen KB, Tennant A, Hetland ML, et al
    Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias.
    Scand J Rheumatol. 2020;49:1-7.
    PubMed     Abstract available


  90. MINALI PA, Pimentel C, de Mello MT, Lima G, et al
    Effectiveness of resistance exercise in functional fitness in women with primary Sjogren's syndrome: randomized clinical trial.
    Scand J Rheumatol. 2020;49:47-56.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: